Wednesday, March 9, 2011

Palliative Care and Medicaid

Eric Widera at GeriPal blog reporting on a new study by Sean Morrison and others showing that hospital based palliative care services reduce Medicaid costs.

Results of this study were via Eric:
  • Patients receiving palliative care consultations had on average a $6,900 reduction in hospital costs per admission.
  • Patients who were discharged alive and received palliative care had an average decrease in hospital costs of $4,098 per admission
  • Patients who died in the hospital and received palliative care had an average decrease in hospital costs of $7,563.
The study like most in this field couldn't relate detailed measures of quality to the cost of care, though patients receiving palliative care were less likely to die in an intensive care unit and had fewer days in the hospital. Patients had a variety of primary diseases, were insured by Medicaid only, and had a hospital stay of 4 days or longer.

I need to read the study closely, but palliative care continues to be shown to be advantageous to costs in a variety of settings and to improve quality. However, I think more work remains to be done to more precisely document the relationship between length of use of palliative care of all types (hospice as well as non hospice palliative care) and quality of care. In policy terms this is very important, because it goes to the issue of how important it is to extend length of hospice use from the 25th percentile of 5 days to the median of around 20 days. There is evidence that such an increase will reduce costs, but it is not clear how much such an increase will improve quality. This detail helps determine how important such expansions are from the patient perspective.

I have a new grant funded by the HCFO Initiative at RWJ Foundation along with Amy Abernethy at Duke that will investigate this question in a prospective manner, looking at both hospice and non hospice palliative care in conjunction with Janet Bull and colleagues at Four Seasons. More on this soon.

2 comments:

  1. "There is evidence that such an increase will reduce costs, but it is not clear how much such an increase will improve quality. This detail helps determine how important such expansions are from the patient perspective. "

    Don
    In the end though, as you know, it is about value.

    It is not about improving quality, but maintaining it--so even without a substantive change in that realm, with a reduction in cost...it's a no brainer.

    My point is, we can just focus on costs, so long as we don't degrade patient experience. That is only one approach on the value pathway.

    Brad

    ReplyDelete
  2. Brad
    yes, if reduces costs and holds constant quality, an easy call to expand palliative care and reduce costs. One reason that pall care care can reduce costs is how expensive the 'normal care' group happens to be.

    Interestingly, I have talked with a few congressional staffer types who basically said 'that is too good to be true' meaning reduce cost and improve quality. There are not so many medical care examples where this is true. Typical question is intervention that is expensive and adds cost and question is how much does it improve quality and/or extend life and then you have the discussion about whether it is 'worth it.'

    ReplyDelete